ICICI Direct: Narayana Hrudayalaya Q2 Review - Steady Improvement In Tough Times
Narayana Multispeciality clinic in Sarjapura (image: Company website)

ICICI Direct: Narayana Hrudayalaya Q2 Review - Steady Improvement In Tough Times


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Narayana Hrudayalaya Ltd.’s recovery in financial performance post Covid-19 was better than expected.

Revenues grew 52.7% QoQ to Rs 600.7 crore (down 26.9% YoY) due to strong recovery seen across mature and new hospitals.

Ebitda margins were at 4.5% against -23.1% in Q1 FY21 and 14.8% in Q2 FY20, with sequential improvement in margins seen amid better operational leverage.

Net loss for the quarter was at Rs 3.4 crore against loss of Rs 119.7 crore in Q1 FY21 (profit of Rs 45.3 crore in Q2 FY20).

Click on the attachment to read the full report:

ICICI Direct Narayana Hrudayalaya Q2FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.